Happy Diwali
from all of us at RetailBonds
CRISIL · 2026-07-10
Laborate Pharmaceuticals India Limited upgraded to A+ by CRISIL — 10 Jul 2026
CRISIL upgraded Laborate Pharmaceuticals India Limited on 2026-07-10, rating A+ with a Stable outlook. No other actions on file yet.
CRISIL's published heading: “Long-term rating upgraded to 'Crisil A+/Stable'; Short-term rating reaffirmed”
| Entity (per CRISIL heading) | Laborate Pharmaceuticals India Limited · issuer page |
| Action | Upgrade |
| Rating | A+ |
| Outlook | Stable |
| Action date | 2026-07-10 |
| Agency | CRISIL |
| Source | CRISIL rating rationale ↗ |
About this page: This page restates a rating action as published by CRISIL, a SEBI-registered credit rating agency. The rating and any outlook are the agency's opinion, not RetailBonds.in's, and nothing here is investment advice or a view on what the action means for any investor. Refer to the agency's own rationale document for the full reasoning. See our methodology and full disclaimer.